Prehliadač alebo jeho nastavenia nie sú podporované.

Praktik.ai používa moderné webové technológie kvôli bezpečnosti, rýchlosti a spoľahlivému prihlasovaniu. Tento prehliadač ich nepodporuje alebo blokuje JavaScript, preto sa aplikácia nemusí správne načítať.

Aktualizujte prosím Chrome, Edge, Firefox alebo Safari na najnovšiu verziu a stránku potom obnovte.

Ak používate Windows 7, Windows 8 alebo Windows 8.1, Chrome a Edge už nemusia ponúkať novú verziu. V takom prípade použite novšie zariadenie alebo kontaktujte podporu Praktik.ai.

Prohlížeč nebo jeho nastavení nejsou podporované.

Praktik.ai používá moderní webové technologie kvůli bezpečnosti, rychlosti a spolehlivému přihlašování. Tento prohlížeč je nepodporuje nebo blokuje JavaScript, proto se aplikace nemusí správně načíst.

Aktualizujte prosím Chrome, Edge, Firefox nebo Safari na nejnovější verzi a stránku potom obnovte.

Pokud používáte Windows 7, Windows 8 nebo Windows 8.1, Chrome a Edge už nemusí nabízet novou verzi. V takovém případě použijte novější zařízení nebo kontaktujte podporu Praktik.ai.

Your browser or its settings are not supported.

Praktik.ai uses modern web technologies for security, speed, and reliable sign-in. This browser does not support them, or JavaScript is blocked, so the app may not load correctly.

Please update Chrome, Edge, Firefox, or Safari to the latest version and then reload this page.

If you use Windows 7, Windows 8, or Windows 8.1, Chrome and Edge may no longer offer a newer version. In that case, use a newer device or contact Praktik.ai support.

Not effective COMMISSION DECISION of 28 June 2013 appointing members and alternates of the Committee for Advanced Therapies to represent clinicians and patients' associations (Text with EEA relevance)

Rozhodnutie č. 629/2013

Text language

Important dates

Declared: 28. júna 2013
Approved: 28. júna 2013
Effective from: 1. júla 2013
Effective until: 1. júla 2016

Documents and links

COMMISSION DECISION

of 28 June 2013

appointing members and alternates of the Committee for Advanced Therapies to represent clinicians and patients' associations

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (1), and in particular Article 21(1) thereof,

Whereas:

(1)

Regulation (EC) No 1394/2007 lays down specific rules concerning the authorisation, supervision and pharmacovigilance of advanced therapy medicinal products. Article 20 of that Regulation lays down that a Committee for Advanced Therapies shall be established within the European Medicines Agency.

(2)

Subparagraph (c) of Article 21(1) of Regulation (EC) No 1394/2007 lays down that the Committee for Advanced Therapies shall include two members and two alternates appointed by the Commission, on the basis of a public call for expressions of interest and after consulting the European Parliament, in order to represent clinicians.

(3)

Subparagraph (d) of Article 21(1) of Regulation (EC) No 1394/2007 lays down that the Committee for Advanced Therapies shall include two members and two alternates appointed by the Commission, on the basis of a public call for expressions of interest and after consulting the European Parliament, in order to represent patients' associations.

(4)

In accordance with Article 21(3) of Regulation (EC) No 1394/2007, the members and alternates of the Committee for Advanced Therapies are appointed for a period of 3 years. The term of office of the members and alternates appointed in 2009 has expired and therefore a new call has been undertaken in 2012.

(5)

In accordance with Article 21(1) of Regulation (EC) No 1394/2007, a public call for expression of interest has been undertaken by the Commission. The European Parliament has been consulted on the results of the evaluation of the applications received,

HAS ADOPTED THIS DECISION:

Article 1

The following are hereby appointed members and alternates of the Committee for Advanced Therapies to represent clinicians for a term of 3 years, from 1 July 2013:

—

Pieter DOEVENDANS (Member) and Esteve TRIAS (Alternate),

—

Bernd GÄNSBACHER (Member) and Ramadan JASHARI (Alternate).

Article 2

The following are hereby appointed members and alternates of the Committee for Advanced Therapies to represent patients' associations for a term of 3 years, from 1 July 2013:

—

Michele LIPUCCI DI PAOLA (Member) and Monica ENSINI (Alternate),

—

Kieran BREEN (Member) and Mariette DRIESSENS (Alternate).

Done at Brussels, 28 June 2013.

For the Commission

Tonio BORG

Member of the Commission

Poznámky